Position in CTMX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$338,400
+$48,720 QoQ
Shares Held
72,000
+5.9% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#96
of 178 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Miller Financial Services LLC holds $1,335,571 across 9 Biotechnology names. CTMX ranks #1 (25.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTMX |
CytomX Therapeutics, Inc.
This page
|
72,000 | $338,400 | |
| 2 | PTN |
Palatin Technologies Inc
|
12,600 | $219,492 | |
| 3 | PSTV |
Plus Therapeutics, Inc.
|
50,000 | $203,250 | |
| 4 | IVVD |
Invivyd, Inc.
|
105,000 | $136,500 | |
| 5 | RNAC |
Cartesian Therapeutics, Inc.
|
22,143 | $136,179 | |
| 6 | IRD |
Opus Genetics, Inc.
|
22,000 | $100,100 | |
| 7 | NNVC |
Nanoviricides, Inc.
|
105,000 | $95,550 | |
| 8 | DTIL |
Precision Biosciences Inc
|
17,000 | $93,500 |
All Filings in CTMX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $338,400 | 72,000 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $289,680 | 68,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $213,730 | 67,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $115,770 | 51,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $32,436 | 51,000 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $25,750 | 25,000 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||